Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez, R. D.
Right arrow Articles by Waller, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez, R. D.
Right arrow Articles by Waller, E. K.
Related Collections
Right arrow Immunobiology
Right arrow Immunotherapy
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 December 2000, Vol. 96, No. 12, pp. 3827-3837

IMMUNOBIOLOGY

CD2-mediated IL-12-dependent signals render human gamma delta -T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies

Richard D. Lopez, Shan Xu, Ben Guo, Robert S. Negrin, and Edmund K. Waller

From the Division of Bone Marrow Transplantation, Stanford University School of Medicine, Stanford, CA; the Division of Hematology/Oncology, Bone Marrow Transplant-Leukemia Program, Emory University School of Medicine, Atlanta, GA; and the Bone Marrow Transplantation Program, University of Alabama at Birmingham, AL.

The ability of human gamma delta -T cells to mediate a number of in vitro functions, including innate antitumor and antiviral activity, suggests these cells can be exploited in selected examples of adoptive immunotherapy. To date, however, studies to examine such issues on a clinical scale have not been possible, owing in large measure to the difficulty of obtaining sufficient numbers of viable human gamma delta -T cells given their relative infrequency in readily available tissues. Standard methods used to expand human T cells often use a combination of mitogens, such as anti-T-cell receptor antibody OKT3 and interleukin (IL)-2. These stimuli, though promoting the expansion of alpha beta -T cells, usually do not promote the efficient expansion of gamma delta -T cells. CD2-mediated, IL-12-dependent signals that result in the selective expansion of human gamma delta -T cells from cultures of mitogen-stimulated human peripheral blood mononuclear cells are identified. It is first established that human gamma delta -T cells are exquisitely sensitive to apoptosis induced by T-cell mitogens OKT3 and IL-2. Next it is shown that the CD2-mediated IL-12-dependent signals, which lead to the expansion of gamma delta -T cells, do so by selectively protecting subsets of human gamma delta -T cells from mitogen-induced apoptosis. Finally, it is demonstrated that apoptosis-resistant gamma delta -T cells are capable of mediating significant antitumor cytotoxicity against a panel of human-derived tumor cell lines in vitro. Both the biologic and the practical implications of induced resistance to apoptosis in gamma delta -T cells are considered and discussed because these findings may play a role in the development of new forms of adoptive cellular immunotherapy.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
Z. Liu, I.-E. A. Eltoum, B. Guo, B. H. Beck, G. A. Cloud, and R. D. Lopez
Protective Immunosurveillance and Therapeutic Antitumor Activity of {gamma}{delta} T Cells Demonstrated in a Mouse Model of Prostate Cancer
J. Immunol., May 1, 2008; 180(9): 6044 - 6053.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. S. Percival, J. F. Bukowski, and J. Milner
Bioactive Food Components that Enhance {gamma}{delta} T Cell Function May Play a Role in Cancer Prevention
J. Nutr., January 1, 2008; 138(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Conti, R. Casetti, M. Cardone, B. Varano, A. Martino, F. Belardelli, F. Poccia, and S. Gessani
Reciprocal Activating Interaction Between Dendritic Cells and Pamidronate-Stimulated {gamma}{delta} T Cells: Role of CD86 and Inflammatory Cytokines
J. Immunol., January 1, 2005; 174(1): 252 - 260.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020